Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia. - Wikidata - wikimedia - TriplyDB

Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.

Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.

http://www.wikidata.org/entity/Q41771344

about

Kynurenines in CNS disease: regulation by inflammatory cytokines Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials Kynurenine pathway metabolites and suicidality The role of inflammation in schizophrenia Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology Glia in the cytokine-mediated onset of depression: fine tuning the immune response The role of inflammation in suicidal behaviour Kynurenines in the mammalian brain: when physiology meets pathology Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia Biochemical, histopathological and morphological profiling of a rat model of early immune stimulation: relation to psychopathology Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats Chronic Toxoplasma gondii in Nurr1-null heterozygous mice exacerbates elevated open field activity Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid.Inflammation and the two-hit hypothesis of schizophrenia.Stress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intolerance Neuromapping techniques in drug discovery: pharmacological MRI for the assessment of novel antipsychotics.A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice Systemic L-Kynurenine sulfate administration disrupts object recognition memory, alters open field behavior and decreases c-Fos immunopositivity in C57Bl/6 mice.Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies.Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects.Traumatic brain injury-induced ependymal ciliary loss decreases cerebral spinal fluid flow.A polygenic burden of rare disruptive mutations in schizophrenia.IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia.Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring.A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia.Translating glutamate: from pathophysiology to treatment.Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal Cord Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia Is there a role for immune-to-brain communication in schizophrenia?Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies Modeling neurodevelopmental cognitive deficits in tasks with cross-species translational validity A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder.

P2860

Q21129356-F6BCD5AA-FB6C-40B9-898C-03A5741A601E Q24623659-8CA8BC87-8286-449B-8661-AB20C59BB5E0 Q24631189-2D1A5C20-19BC-48EE-8FAD-087EDAEE3910 Q26741541-07BA37BB-4335-4684-ADD6-0AE367402864 Q26773067-C046C585-C7CC-49FD-A253-1E20CFC7AC81 Q26779719-7497D610-C9C2-4AAC-91C4-444A5BC32167 Q26782867-6C16A2EC-A09C-4315-AA5E-776AE7E38C54 Q26798929-223E5D0E-0EE9-4427-AEBB-E08C98BFD454 Q26800426-3900A9F7-8825-4BED-BDD3-26F0EB7DBE46 Q27003296-25ACA762-E6A9-4352-B0FE-0BFA2D7A304B Q28270694-C7328284-2CB8-456E-BF91-AF9D35D323C4 Q28543041-DD6DEDBF-7BF4-4007-8E68-FD3170AB180D Q30408061-BB20AF53-40FB-4004-80E8-6A86109AA469 Q30413968-519BC73D-1C70-4AC1-AAD9-054C9EC28C87 Q30419650-8F8C1583-894A-4994-9420-561C658648E2 Q30422062-AA57BAD3-766D-4E66-B7D8-4DF6A8DF9CF3 Q30426795-123318A3-7EEA-4A4B-913F-DD4B47028D40 Q30564474-380ADB82-CE2A-42FA-8DAC-C54D36C66A5B Q30651885-E5380E6B-000C-4C3C-9BC3-9984864BE5FD Q30654478-1F42B421-33DA-4B54-95D6-45A2D7879FE5 Q33572850-E58B699D-70EA-4680-9AB4-BB32F6EE69EE Q33583816-2CF40B99-4558-463D-A5AC-E6B5D8F09D4B Q34043836-1C8D7399-13B1-4F76-BDC7-6CE98A5DB24B Q34060200-1885E948-9445-4E1F-A510-9C7FBD583878 Q34764938-8FA63EB7-7C7F-4F7F-984E-5EFDD7B83B02 Q35162796-419CBA16-19AD-4FBE-8A7E-CFD3CDF1C9AB Q35202246-46802DFD-5781-4042-B502-A45576D8D7FA Q35213516-6CD7FEC6-EA05-4072-9024-78A97479D9C7 Q35225947-5EF4B024-331D-43C2-9F63-C6237274ACB4 Q35390305-DEE7B570-0CEE-4062-A807-0C68AFB76A8C Q35739457-47470C27-4889-4177-B102-E0F9A341F0C1 Q35840053-FC1F6581-E338-4F2E-900C-39CF31DAE972 Q35892576-14674F16-8CE3-44F2-8621-560123ED1A8B Q36351021-E986F2D1-7236-4550-B63D-35720C7A25C4 Q36579965-0BC9EF1C-EEC6-4759-B731-A868CD421661 Q36634249-5B884421-642A-4F72-B03F-18064372D935 Q36778677-F91E55C9-D01F-4C80-83B3-BB5F82B06673 Q37114639-5C71C552-40EC-4A4C-9650-72AE9A9EACB4 Q37126507-33743554-A068-4869-8BDA-23ED04F91441 Q37136385-B66C8DAA-C836-4825-8427-1960E947159A

P2860

Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.

http://www.wikidata.org/entity/Q41771344

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Increased levels of kynurenine ...... f patients with schizophrenia.

@en

type

label

Increased levels of kynurenine ...... f patients with schizophrenia.

@en

prefLabel

Increased levels of kynurenine ...... f patients with schizophrenia.

@en

P1433

Q41771344-B4EDF467-0F89-4C96-9C12-08949D84F52B

P1476

Q41771344-E389DDBA-4567-4E74-A013-2D512B7B45E3

P2093

Q41771344-247E680E-A17D-44FF-962D-6A676B761FAF

Q41771344-51FD0EDC-54BF-4166-AD83-4CBEB2207477

Q41771344-8CA86C29-F854-4EC8-8238-4A418F533B12

Q41771344-CD2F23D7-107C-4C28-B324-306FA8E6C608

Q41771344-DAB5E097-55AC-4C85-AE25-5D83D7BF48DD

Q41771344-E3339E69-729B-4ED7-A0C2-3AD51DD071F4

P2860

Q41771344-00688690-9232-4F69-AEC5-1A921AF18ECF

Q41771344-01F48231-BD97-4698-8EDD-D324CBE575BD

Q41771344-044DA59E-C187-44B8-AAC1-B41B36D4B08C

Q41771344-046FB609-B178-4726-AE71-246F6AB00A95

Q41771344-078C0F20-638C-4DE3-844B-2E25D9AD805B

Q41771344-07CB4694-EDBD-46AC-826E-9C8A322074A1

Q41771344-0E4026C9-EA86-4D5E-A886-E23CFDC9E8B0

Q41771344-12916156-AF61-4D88-ABC0-F74B238601C7

Q41771344-192112B9-A724-417A-8BDE-1A03B825A824

Q41771344-25F3E4B3-9185-4355-ADAC-0734FC9C8ECB

P304

Q41771344-6017956E-5146-4C58-B328-2B9A7ECB16DA

P31

Q41771344-5C7EE418-0749-4F9F-9F8D-F1DBDE1AB90F

P356

Q41771344-63C48162-EE94-4DE0-B626-BDF1B3D7C31F

P407

Q41771344-8FB65F67-0F33-4836-93CE-983AF6B48CE0

P433

Q41771344-BF447EB6-2C39-40C1-8D30-3B0211DC60E5

P478

Q41771344-B8945283-D474-4043-A410-94646A4264C9

P50

Q41771344-53FD0C7B-8608-4735-90BD-1C7F46B4C832

Q41771344-8633CD07-7A52-43EF-9BD6-7A8D1B753BAF

P577

Q41771344-C1FC0DA6-C83D-4785-B22A-334B8F7F5F29

P5875

Q41771344-4A7533F0-54D7-4DBB-8105-D33824A5AAF8

P698

Q41771344-C7C1D442-89F6-4240-9C8C-38954117D93E

P921

Q41771344-A53CCB6F-FC22-46BD-A08F-8F73BD05B34A

P932

Q41771344-32B29CA6-A73D-44CA-916D-F738D3A87D09

P356

P1433

Schizophrenia Bulletin

P1476

Increased levels of kynurenine ...... of patients with schizophrenia

@en

P2093

Elisabeth Skogh

http://www.w3.org/2001/XMLSchema#string

Göran Engberg

http://www.w3.org/2001/XMLSchema#string

Klas R Linderholm

http://www.w3.org/2001/XMLSchema#string

Maria Holtze

http://www.w3.org/2001/XMLSchema#string

Marja-Liisa Dahl

http://www.w3.org/2001/XMLSchema#string

Sara K Olsson

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior.

From inflammation to sickness and depression: when the immune system subjugates the brain

Mammalian nicotinic acetylcholine receptors: from structure to function

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

Prestimulus effects on human startle reflex in normals and schizophrenics

Tripartite synapses: glia, the unacknowledged partner

Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice.

Elevations of endogenous kynurenic acid produce spatial working memory deficits.

Pharmacologically elevated levels of endogenous kynurenic acid prevent nicotine-induced activation of nigral dopamine neurons.

P304

426-432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/SCHBUL/SBQ086

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Martin Samuelsson

P577

2010-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45799886

http://www.w3.org/2001/XMLSchema#string

P698

20729465

http://www.w3.org/2001/XMLSchema#string

P921

P932

3329991

http://www.w3.org/2001/XMLSchema#string